<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//longeveron.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://longeveron.com/publications/</loc>
		<lastmod>2026-06-23T21:31:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://longeveron.com/publications/nature-medicine-allogeneic-mesenchymal-stem-cell-therapy-with-laromestrocel-in-mild-alzheimers-disease-a-randomized-controlled-phase-2a-trial/</loc>
		<lastmod>2026-05-18T13:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://longeveron.com/publications/the-design-and-rationale-of-a-phase-2b-randomized-double-blinded-and-placebo-controlled-trial-to-evaluate-the-safety-and-efficacy-of-lomecel-b-in-older-adults-with-frailty-j-frailty-aging/</loc>
		<lastmod>2026-05-18T13:44:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://longeveron.com/publications/allogeneic-mesenchymal-stem-cells-ameliorate-aging-frailty-a-phase-ii-randomized-double-blind-placebo-controlled-clinical-trial/</loc>
		<lastmod>2026-05-18T13:48:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://longeveron.com/publications/randomized-comparison-of-allogeneic-versus-autologous-mesenchymal-stem-cells-for-nonischemic-dilated-cardiomyopathy-poseidon-dcm-trial/</loc>
		<lastmod>2026-05-18T13:48:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://longeveron.com/publications/intramyocardial-cell-based-therapy-with-lomecel-b-during-bidirectional-cavopulmonary-anastomosis-for-hypoplastic-left-heart-syndrome-the-elpis-phase-i-trial/</loc>
		<lastmod>2026-05-18T13:49:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://longeveron.com/publications/results-and-insights-from-a-phase-i-clinical-trial-of-lomecel-b-for-alzheimers-disease/</loc>
		<lastmod>2026-05-18T13:50:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://longeveron.com/publications/allogeneic-mesenchymal-stem-cell-therapy-a-regenerative-medicine-approach-to-geroscience/</loc>
		<lastmod>2026-05-18T13:50:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://longeveron.com/publications/allogeneic-human-mesenchymal-stem-cell-infusions-for-aging-frailty/</loc>
		<lastmod>2026-05-18T13:51:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://longeveron.com/publications/randomized-phase-2b-dose-escalation-trial-of-stem-cell-therapy-with-laromestrocel-for-aging-frailty/</loc>
		<lastmod>2026-06-23T21:31:14+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->